These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1340772)

  • 1. Lenticular burns following argon panretinal photocoagulation.
    Bloom SM; Mahl CF; Schiller SB
    Br J Ophthalmol; 1992 Oct; 76(10):630-1. PubMed ID: 1340772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakdown of the blood-aqueous barrier after argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
    Moriarty AP; Spalton DJ; Shilling JS; Ffytche TJ; Bulsara M
    Ophthalmology; 1996 May; 103(5):833-8. PubMed ID: 8637696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation.
    Seiberth V; Schatanek S; Alexandridis E
    Graefes Arch Clin Exp Ophthalmol; 1993 Jun; 231(6):318-22. PubMed ID: 8339946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
    Blankenship GW
    Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior segment complications of indirect diode laser in diabetic patients.
    Buckley SA; Parmar DN; Jackson H; McHugh JD; Hunter PA
    Br J Ophthalmol; 1998 Dec; 82(12):1447-8. PubMed ID: 9930285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observation on clinical effects of panretinal coagulation for diabetic retinopathy].
    Qian Z; Zhu L; Zhao C
    Yan Ke Xue Bao; 2002 Jun; 18(2):99-101. PubMed ID: 15510646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated pupils and loss of accommodation following diode panretinal photocoagulation with sub-tenon local anaesthetic in four cases.
    Patel JI; Jenkins L; Benjamin L; Webber S
    Eye (Lond); 2002 Sep; 16(5):628-32. PubMed ID: 12194080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ciliochoroidal effusion after panretinal photocoagulation.
    Gentile RC; Stegman Z; Liebmann JM; Dayan AR; Tello C; Walsh JB; Ritch R
    Ophthalmology; 1996 May; 103(5):827-32. PubMed ID: 8637695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dye yellow vs. argon green laser in panretinal photocoagulation for proliferative diabetic retinopathy: a comparison of minimum power requirements.
    Castillejos-Rios D; Devenyi R; Moffat K; Yu E
    Can J Ophthalmol; 1992 Aug; 27(5):243-4. PubMed ID: 1393811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of proliferative diabetic retinopathy in which scintillating particles appeared in the intravitreal cavity after laser photocoagulation.
    Kohmoto R; Kobayashi T; Sato T; Kimura D; Fukumoto M; Tajiri K; Kida T; Ikeda T
    BMC Ophthalmol; 2017 Dec; 17(1):254. PubMed ID: 29258460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications of photocoagulation for diabetic retinopathy].
    de Laey JJ
    Diabete Metab; 1993; 19(5):430-5. PubMed ID: 8056122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy.
    Cordeiro MF; Stanford MR; Phillips PM; Shilling JS
    Eye (Lond); 1997; 11 ( Pt 4)():531-6. PubMed ID: 9425420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic correlation of xenon arc and argon laser photocoagulation. Procedure in human diabetic eyes.
    Wallow IH; Davis MD
    Arch Ophthalmol; 1979 Dec; 97(12):2308-15. PubMed ID: 574760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical observation on argon green laser in the treatment of diabetic macular edema].
    Qin B; Guo XJ; Tang CZ
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):551-2. PubMed ID: 12658939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personal experience in the treatment of proliferative diabetic retinopathy using an argon laser].
    Chrapek O; Rehák J
    Cesk Slov Oftalmol; 2001 Jul; 57(4):244-9. PubMed ID: 11512438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The loss of visual field after proliferative diabetic retinopathy treatment with two different techniques of panretinal photocoagulation].
    Kovacić Z; Ivanisević M; Karelović D
    Acta Med Croatica; 2007 Apr; 61(2):149-52. PubMed ID: 17585469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferative diabetic retinopathy: laser photocoagulation treatment].
    Snyers B
    Bull Soc Belge Ophtalmol; 1995; 256():87-94. PubMed ID: 8581236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Effect of Panretinal Photocoagulation on Spectral Domain Optical Coherence Tomography Measurements in Diabetic Retinopathy.
    Lee HJ; Kang TS; Kwak BS; Jo YJ; Kim JY
    Curr Eye Res; 2017 Aug; 42(8):1169-1173. PubMed ID: 28339297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of argon laser retinal photocoagulation: a five-year study.
    Little HL
    Int Ophthalmol Clin; 1976; 16(4):145-59. PubMed ID: 1033162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.